ArticleJournal of translational medicine2023

CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway.

Chuanzheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.